Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Web-Based App to Help Clinicians Improve Patient Care

Published: Wednesday, September 12, 2012
Last Updated: Wednesday, September 12, 2012
Bookmark and Share
PROOF Centre of Excellence & IO Informatics collaborate to bring precision medicine to the point of care.

The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and IO Informatics are partnering to develop new tools for clinicians to address chronic heart, lung and kidney disease.
The collaboration brings together the PROOF Centre’s award-winning science and IO Informatics’ leading software and semantic integration services to create a web-based software application for clinicians to use on hand-held devices or other technology. The application will be used with the PROOF Centre-developed blood tests in chronic disease and transplantation.

The application will provide clinicians with an overall score indicating patient risk level, along with the associated clinical recommendations to help guide clinical decision-making. Using gene expression data, protein expression data, and longitudinal clinical observations as inputs, the system will be a web-based reporting and alerting system accessible by clinicians securely through web browsers on workstations, laptops or standards-compliant mobile devices.

“This collaborative project represents a major step forward to realizing the promise of biomarker-based screening for precision medicine and better healthcare at lower cost,” said Dr. Bruce McManus, Director of the PROOF Centre. “By bringing together science and technology and applying it to a very real clinical need, we are creating a simple tool to help improve the care and management of patients with chronic heart, lung and kidney disease and ultimately reducing patient suffering and healthcare costs.”

Heart, lung and kidney diseases together are an oppressive growing health burden in Canada and around the world. The socio-economic impact of impaired organ failure for millions of suffering patients is far from trivial. The rising costs associated with these health conditions are an enormous toll on an already over-burdened health system. New tools to allow for early intervention that will improve the efficiency of patient care and management, and lower health care costs are needed to help address the burden. The PROOF Centre works closely with clinicians to develop new blood tests that improve the way patients are managed and bring value to the health system.

“We are excited about the opportunity to add value to the PROOF Centre’s blood test development programs. It is very rewarding to be part of a solution that will make a difference in so many patients’ quality of life,” says Dr. Erich Gombocz, Vice-President and Chief Science Officer for IO Informatics. “In addition to immediate benefits for patients, future applications of this technology will enable automated, pre-symptomatic screening for virtually any marker-based risk event, disease severity characterization or patient-centric treatment opportunity.”

By spring of 2013, the PROOF Centre will have blood tests integrated with the web-based application and ready for testing in the clinic.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Pittcon 2016: Accelerating Innovation And Enhancing Productivity With Technology
Collaboration and externalization of data highlight evolving lab operations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!